Many bacteriophages can modulate host transcription. Here, the authors uncover the anti-termination mechanism of phage satellite P4 protein, Psu. Psu dimers clamp two open rings of the termination ...

Effie did her PhD studies in Athens on mechanisms of stochastic gene expression. In 2009, she moved to MGH and Harvard Stem Cell institute in Boston to unravel epigenetic mechanisms that drive somatic ...

The crucial role of porous catalysts in the electrochemical reduction of carbon dioxide. The review study explores the synthesis techniques, design strategies, and reaction mechanisms of porous ...

For the multifaceted and complex diseases, multi-omics could define groups of patients with distinct endotypes exhibiting heterogeneous treatment responses due to their particular underlying molecular ...

It’s historically discounted relative to the peer group, with more in the way of positive catalysts in the new year. While most others are focused on the negatives of the past, I think it’s ...

From Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Victoria, Australia (R.H.R.) Division of Endocrinology and Metabolism (E.D.A.), ...

while sometimes an "abiding expression of faith," is also a culturally conditioned survival mechanism. For "people at the margins," she writes, extending "forgiveness" is sometimes a necessary ...

New research identifies key cellular mechanism driving Alzheimer's disease. ScienceDaily . Retrieved January 20, 2025 from www.sciencedaily.com / releases / 2024 / 12 / 241223135051.htm ...

A closely followed crypto analyst is lining up six key events that could trigger the next big move up for altcoins. In a new YouTube update, the host of InvestAnswers lays out six potential catalysts ...

Gold has gained nearly 27% this year US jobs data, December Fed meeting minutes due next week Platinum hit over three-month low on Friday Dec 30 (Reuters) - Gold prices dipped in thin trade on ...

Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next year, with key trial readouts expected from companies including Moderna ...